Cogent Biosciences
Facts
as of Nov 16, 2026Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
It is hiring: 7 open roles, 1 of them posted in the last 30 days.
- Headquarters
- Waltham, United States
- Listing
- NASDAQ: COGT
- Open roles
- 7 in 2 citiesAlion job postings
- Official records
- Wikidata Q119857276
- Website
- cogentbio.com
As of Nov 16, 2026, Alion lists 7 open roles at Cogent Biosciences. Cogent Biosciences is headquartered in Waltham, United States.
What the registers and the postings say about this employer.
Hiring
All open roles →Hiring slowly: few roles were posted lately.
Biotech is the largest family, 40 of open roles.
Visa
Full chapter →Named in the work visa registers of United States.
In the register as Cogent Biosciences Inc., Waltham, MA (+1 more)
Footprint
Hiring in 2 cities in 1 country.
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Waltham United States | Headquarters | 5 | Finance, Biotech | 0% |
| Boulder United States | Regional office | 2 | Administrative, Biotech | 0% |
Tech stack
Full chapter →Technologies named in job postings at Cogent Biosciences over the last 12 months, by layer, with the share of postings for each.
